PATHOGENESIS OF NONKETOTIC HYPEROSMOLAR DIABETIC COMA

B. I. Joffe, L. H. Krut, Ronald B Goldberg, H. C. Seftel

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Two concepts are advanced to explain some of the puzzling biochemical features found in nonketotic hyperosmolar diabetic coma. It is firstly suggested that an insulinised liver (reflecting residual beta-cell secretory activity) coexists with a diabetic periphery, thereby inactivating intrahepatic oxidation of incoming free fatty acids, which are directed largely along nonketogenic metabolic pathways such as triglyceride synthesis. This could account for the lack of hyperketonæmia. Secondly, it is hypothesised that within the liver enhanced neoglucogenesis occurs, due to the prevailing portal-vein ratio of glucagon to insulin, and is mainly responsible for the development of massive hyperglycæmia.

Original languageEnglish
Pages (from-to)1069-1071
Number of pages3
JournalThe Lancet
Volume305
Issue number7915
DOIs
StatePublished - May 10 1975
Externally publishedYes

Fingerprint

Hyperglycemic Hyperosmolar Nonketotic Coma
Diabetic Coma
Liver
Portal Vein
Metabolic Networks and Pathways
Glucagon
Nonesterified Fatty Acids
Triglycerides
Insulin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

PATHOGENESIS OF NONKETOTIC HYPEROSMOLAR DIABETIC COMA. / Joffe, B. I.; Krut, L. H.; Goldberg, Ronald B; Seftel, H. C.

In: The Lancet, Vol. 305, No. 7915, 10.05.1975, p. 1069-1071.

Research output: Contribution to journalArticle

Joffe, B. I. ; Krut, L. H. ; Goldberg, Ronald B ; Seftel, H. C. / PATHOGENESIS OF NONKETOTIC HYPEROSMOLAR DIABETIC COMA. In: The Lancet. 1975 ; Vol. 305, No. 7915. pp. 1069-1071.
@article{9d727ba59d024886b0717bc1c0e32196,
title = "PATHOGENESIS OF NONKETOTIC HYPEROSMOLAR DIABETIC COMA",
abstract = "Two concepts are advanced to explain some of the puzzling biochemical features found in nonketotic hyperosmolar diabetic coma. It is firstly suggested that an insulinised liver (reflecting residual beta-cell secretory activity) coexists with a diabetic periphery, thereby inactivating intrahepatic oxidation of incoming free fatty acids, which are directed largely along nonketogenic metabolic pathways such as triglyceride synthesis. This could account for the lack of hyperketon{\ae}mia. Secondly, it is hypothesised that within the liver enhanced neoglucogenesis occurs, due to the prevailing portal-vein ratio of glucagon to insulin, and is mainly responsible for the development of massive hyperglyc{\ae}mia.",
author = "Joffe, {B. I.} and Krut, {L. H.} and Goldberg, {Ronald B} and Seftel, {H. C.}",
year = "1975",
month = "5",
day = "10",
doi = "10.1016/S0140-6736(75)91833-4",
language = "English",
volume = "305",
pages = "1069--1071",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "7915",

}

TY - JOUR

T1 - PATHOGENESIS OF NONKETOTIC HYPEROSMOLAR DIABETIC COMA

AU - Joffe, B. I.

AU - Krut, L. H.

AU - Goldberg, Ronald B

AU - Seftel, H. C.

PY - 1975/5/10

Y1 - 1975/5/10

N2 - Two concepts are advanced to explain some of the puzzling biochemical features found in nonketotic hyperosmolar diabetic coma. It is firstly suggested that an insulinised liver (reflecting residual beta-cell secretory activity) coexists with a diabetic periphery, thereby inactivating intrahepatic oxidation of incoming free fatty acids, which are directed largely along nonketogenic metabolic pathways such as triglyceride synthesis. This could account for the lack of hyperketonæmia. Secondly, it is hypothesised that within the liver enhanced neoglucogenesis occurs, due to the prevailing portal-vein ratio of glucagon to insulin, and is mainly responsible for the development of massive hyperglycæmia.

AB - Two concepts are advanced to explain some of the puzzling biochemical features found in nonketotic hyperosmolar diabetic coma. It is firstly suggested that an insulinised liver (reflecting residual beta-cell secretory activity) coexists with a diabetic periphery, thereby inactivating intrahepatic oxidation of incoming free fatty acids, which are directed largely along nonketogenic metabolic pathways such as triglyceride synthesis. This could account for the lack of hyperketonæmia. Secondly, it is hypothesised that within the liver enhanced neoglucogenesis occurs, due to the prevailing portal-vein ratio of glucagon to insulin, and is mainly responsible for the development of massive hyperglycæmia.

UR - http://www.scopus.com/inward/record.url?scp=0016722337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016722337&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(75)91833-4

DO - 10.1016/S0140-6736(75)91833-4

M3 - Article

C2 - 48734

AN - SCOPUS:0016722337

VL - 305

SP - 1069

EP - 1071

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 7915

ER -